Literature DB >> 29191806

Atrial fibrillation prevention: an appraisal of current evidence.

Giuseppe Boriani1, Marco Proietti2,3.   

Abstract

Atrial fibrillation (AF), which is the most diagnosed arrhythmia, is becoming a significant issue for health policy-makers. In particular, more and more attention is being devoted to AF prevention. Indeed, several studies recently published point out how targeted interventions could be useful in reducing the risk of AF occurrence (or recurrence). In this review, we briefly summarised the role of the major risk factors associated with the incidence of AF, as well as the effectiveness of interventions aimed at controlling these risk factors. Several general risk factors, such as alcohol consumption, physical activity, smoking habit, as well as specific cardiovascular risk factors as diabetes mellitus, hypertension and obesity have a relevant impact in determining the occurrence of AF, along with a strong clinical evidence of a dose-effect response mechanism for most of the factors examined. Specific interventions aimed at controlling risk factors have been showed to clearly reduce the risk of AF in several cohorts. Even more importantly, integrated programmes aimed at controlling for multiple risk factors would be more efficient in terms of reducing risk of AF, in particular whena stricter control is observed. AF prevention requires a series of initiatives focused on the many risk factors that we reviewed, as well as a more integrated approach, which should involve many stakeholders at different levels. In this light and also considering the constantly changing epidemiology, AF prevention may constitute a future 'win-win' strategy for all the stakeholders. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  atrial fibrillation; cardiac risk factors and prevention; epidemiology; obesity; stroke

Mesh:

Year:  2017        PMID: 29191806     DOI: 10.1136/heartjnl-2017-311546

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

Review 1.  Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes.

Authors:  Giuseppe Boriani; Elena Biagini; Matteo Ziacchi; Vincenzo Livio Malavasi; Marco Vitolo; Marisa Talarico; Erminio Mauro; Giulia Gorlato; Giovanna Lattanzi
Journal:  Nucleus       Date:  2018       Impact factor: 4.197

2.  Prognostic models for predicting incident or recurrent atrial fibrillation: protocol for a systematic review.

Authors:  Janine Dretzke; Naomi Chuchu; Winnie Chua; Larissa Fabritz; Susan Bayliss; Dipak Kotecha; Jonathan J Deeks; Paulus Kirchhof; Yemisi Takwoingi
Journal:  Syst Rev       Date:  2019-08-28

3.  Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.

Authors:  Jun Xiao; Anders P Persson; Gunnar Engström; Linda S B Johnson
Journal:  BMC Cardiovasc Disord       Date:  2021-03-12       Impact factor: 2.298

4.  Integrated Pharmacogenetics Analysis of the Three Fangjis Decoctions for Treating Arrhythmias Based on Molecular Network Patterns.

Authors:  Penglu Wei; Dehuai Long; Yupei Tan; Wenlong Xing; Xiang Li; Kuo Yang; Hongxu Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-24

5.  Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis.

Authors:  Jianqi Hao; Jian Zhou; Wenying Xu; Cong Chen; Jian Zhang; Haoning Peng; Lunxu Liu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-08-20       Impact factor: 1.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.